A Beginner’s Guide to the Antibody Drug Conjugates Market
The Antibody Drug Conjugates Market is gaining remarkable traction as pharmaceutical innovations continue to reshape the landscape of oncology. Antibody-drug conjugates (ADCs) represent a cutting-edge class of biopharmaceuticals that combine the targeting capabilities of monoclonal antibodies with the potent cell-killing ability of cytotoxic drugs.